Accelerating recruitment with an indication-level approach for a portfolio of COPD trials
Therapy area
COPD
Markets
US, Canada, UK, Mexico, Chile
Media
Meta, PPC, Taboola, AdLikeYou, Nextdoor
Overview
To support a pipeline of COPD clinical trials, we created a single, patient-focused media campaign and platform that brought together multiple studies, offering patients a central place to register their interest in participating in a clinical trial.
Our Faze1 Referral Management System was utilised by sites globally and our warm handover team successfully pre-screened and referred over 3000 patients to trial sites.
This approach also allowed us to capture those who weren’t yet eligible, gaining over 10,000 sign ups. Through informative communications like emails and newsletters, we built trust, nurtured potential leads and kept patients engaged and interested until they were ready to be referred to a trial site. This ongoing dialogue ensured that patients stayed informed and motivated throughout the recruitment process.
Behind the Scenes
To ensure our campaign resonated with COPD patients, we took a thoughtful and research-driven approach to creating the key visual. Casting was carefully considered to reflect the lived experiences of those with COPD, making the imagery as relatable as possible. We also researched home interiors in the target regions to ensure authenticity in the final creative. We directed the photoshoot remotely, guiding the cast and crew via video link. To bring the concept to life, we crafted large fabric COPD letters and suspended them around the model on a staircase, visually representing the struggle of breathlessness. The model was photographed in multiple positions while climbing the stairs, giving us flexibility to create a compelling and realistic final composition. In post-production, we refined the setting, ensuring the home details felt true to life, the letterforms had the right inflated effect and the lighting and facial expressions authentically conveyed the daily challenges of living with COPD.
